🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 10 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/01/2020 | 57,39 | 58,33 | 57,20 | 57,72 | +1,41% | 1,98% | 499.014 |
| 15/01/2020 | 56,39 | 57,19 | 56,30 | 56,92 | +0,55% | 1,58% | 647.612 |
| 14/01/2020 | 56,26 | 57,36 | 55,52 | 56,61 | +0,62% | 3,26% | 695.221 |
| 13/01/2020 | 58,15 | 58,16 | 55,38 | 56,26 | -2,98% | 4,78% | 828.430 |
| 10/01/2020 | 59,69 | 59,98 | 57,86 | 57,99 | -2,86% | 3,55% | 549.188 |
| 09/01/2020 | 61,09 | 61,09 | 59,26 | 59,69 | -1,78% | 2,98% | 440.344 |
| 08/01/2020 | 61,60 | 62,37 | 60,73 | 60,77 | -1,58% | 2,66% | 496.930 |
| 07/01/2020 | 62,84 | 63,15 | 61,48 | 61,75 | -2,33% | 2,65% | 463.908 |
| 06/01/2020 | 62,66 | 63,46 | 61,49 | 63,22 | +0,17% | 3,14% | 364.522 |
| 03/01/2020 | 64,36 | 64,60 | 63,08 | 63,11 | -3,41% | 2,37% | 517.288 |
| 02/01/2020 | 65,60 | 65,88 | 64,19 | 65,34 | +0,43% | 2,57% | 344.324 |
| 31/12/2019 | 64,54 | 66,02 | 64,54 | 65,06 | +0,29% | 2,30% | 440.184 |
| 30/12/2019 | 66,58 | 66,96 | 64,58 | 64,87 | -2,69% | 3,57% | 336.790 |
| 27/12/2019 | 67,33 | 67,33 | 65,28 | 66,66 | -0,24% | 3,04% | 401.552 |
| 26/12/2019 | 67,57 | 67,84 | 66,62 | 66,82 | -0,96% | 1,81% | 190.436 |
| 24/12/2019 | 66,30 | 67,64 | 65,73 | 67,47 | +2,19% | 2,88% | 144.751 |
| 23/12/2019 | 66,76 | 66,87 | 64,90 | 66,03 | -0,03% | 2,95% | 397.223 |
| 20/12/2019 | 68,13 | 68,90 | 65,91 | 66,04 | -2,95% | 4,39% | 1.137.970 |
| 19/12/2019 | 67,15 | 68,81 | 66,84 | 68,05 | +1,19% | 2,93% | 428.322 |
| 18/12/2019 | 67,09 | 67,45 | 65,31 | 67,26 | -0,26% | 3,20% | 401.712 |
| 17/12/2019 | 66,47 | 67,59 | 65,38 | 67,43 | +1,53% | 3,32% | 381.674 |
| 16/12/2019 | 66,63 | 67,04 | 65,76 | 66,41 | +0,40% | 1,92% | 334.386 |
| 13/12/2019 | 66,20 | 67,72 | 65,58 | 66,15 | -0,75% | 3,22% | 303.929 |
| 12/12/2019 | 65,07 | 67,02 | 64,36 | 66,65 | +2,51% | 4,09% | 416.940 |
| 11/12/2019 | 66,54 | 67,12 | 64,09 | 65,02 | -2,01% | 4,57% | 625.170 |
| 10/12/2019 | 66,52 | 67,11 | 65,41 | 66,35 | +0,54% | 2,56% | 490.037 |
| 09/12/2019 | 67,69 | 68,12 | 65,91 | 66,00 | -2,05% | 3,26% | 482.343 |
| 06/12/2019 | 66,05 | 67,51 | 65,94 | 67,37 | +2,94% | 2,38% | 560.249 |
| 05/12/2019 | 67,12 | 67,86 | 64,95 | 65,45 | -2,47% | 4,34% | 628.216 |
| 04/12/2019 | 69,69 | 70,44 | 66,99 | 67,11 | -3,09% | 4,94% | 572.271 |